0.080USD
12.67 MUSD
233.66 MUSD
139.66 M
About TG THERAPEUTICS INC COM USD0.001
Sector
CEO
Michael Sean Weiss
Headquarters
Morrisville
Website
Employees (FY)
264
Founded
1993
ISIN
US88322Q1085
FIGI
BBG00LJZ6D55
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0VGI is 14.390 USD — it has increased by 5.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange TG THERAPEUTICS INC COM USD0.001 stocks are traded under the ticker 0VGI.
TG THERAPEUTICS INC COM USD0.001 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0VGI stock is 6.91% volatile and has beta coefficient of 3.40. Check out the list of the most volatile stocks — is TG THERAPEUTICS INC COM USD0.001 there?
One year price forecast for TG THERAPEUTICS INC COM USD0.001 has a max estimate of 45.000 USD and a min estimate of 7.000 USD.
0VGI earnings for the last quarter are 0.73 USD per share, whereas the estimation was 0.06 USD resulting in a 1.18 K% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about TG THERAPEUTICS INC COM USD0.001 earnings.
TG THERAPEUTICS INC COM USD0.001 revenue for the last quarter amounts to 165.82 M USD despite the estimated figure of 23.91 M USD. In the next quarter revenue is expected to reach 40.06 M USD.
Yes, you can track TG THERAPEUTICS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
0VGI stock has fallen by 2.97% compared to the previous week, the month change is a 4.19% fall, over the last year TG THERAPEUTICS INC COM USD0.001 has showed a 31.34% decrease.
0VGI net income for the last quarter is −14.42 M USD, while the quarter before that showed 113.93 M USD of net income which accounts for −112.65% change. Track more TG THERAPEUTICS INC COM USD0.001 financial stats to get the full picture.
Today TG THERAPEUTICS INC COM USD0.001 has the market capitalization of 2.16 B, it has increased by 3.67% over the last week.
No, 0VGI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0VGI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TG THERAPEUTICS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 264.00 employees. See our rating of the largest employees — is TG THERAPEUTICS INC COM USD0.001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TG THERAPEUTICS INC COM USD0.001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TG THERAPEUTICS INC COM USD0.001 stock shows the neutral signal. See more of TG THERAPEUTICS INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TG THERAPEUTICS INC COM USD0.001 future price: according to them, 0VGI price has a max estimate of 45.00 USD and a min estimate of 7.00 USD. Read a more detailed TG THERAPEUTICS INC COM USD0.001 forecast: see what analysts think of TG THERAPEUTICS INC COM USD0.001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TG THERAPEUTICS INC COM USD0.001 EBITDA is 21.06 M USD, and current EBITDA margin is 9.01%. See more stats in TG THERAPEUTICS INC COM USD0.001 financial statements.